These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32167621)

  • 1. Prognostic value of HLA class I expression in patients with oral squamous cell carcinoma.
    Koike K; Dehari H; Shimizu S; Nishiyama K; Sonoda T; Ogi K; Kobayashi J; Sasaki T; Sasaya T; Tsuchihashi K; Tsukahara T; Hasegawa T; Torigoe T; Hiratsuka H; Miyazaki A
    Cancer Sci; 2020 May; 111(5):1491-1499. PubMed ID: 32167621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma.
    Koike K; Dehari H; Ogi K; Shimizu S; Nishiyama K; Sonoda T; Sasaki T; Sasaya T; Tsuchihashi K; Hasegawa T; Torigoe T; Hiratsuka H; Miyazaki A
    PLoS One; 2020; 15(8):e0237465. PubMed ID: 32785290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma.
    Boxberg M; Leising L; Steiger K; Jesinghaus M; Alkhamas A; Mielke M; Pfarr N; Götz C; Wolff KD; Weichert W; Kolk A
    J Immunol; 2019 Jan; 202(1):278-291. PubMed ID: 30530592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
    Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
    Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating CD8
    Shimizu S; Hiratsuka H; Koike K; Tsuchihashi K; Sonoda T; Ogi K; Miyakawa A; Kobayashi J; Kaneko T; Igarashi T; Hasegawa T; Miyazaki A
    Cancer Med; 2019 Jan; 8(1):80-93. PubMed ID: 30600646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 Expression Confers Better Prognosis in Locally Advanced Oral Squamous Cell Carcinoma.
    Kogashiwa Y; Yasuda M; Sakurai H; Nakahira M; Sano Y; Gonda K; Ikeda T; Inoue H; Kuba K; Oba S; Ishikawa J; Enoki Y; Matsumura S; Minami K; Ebihara Y; Sugasawa M
    Anticancer Res; 2017 Mar; 37(3):1417-1424. PubMed ID: 28314313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Density and location of CD3
    Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
    J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients.
    Ogino T; Bandoh N; Hayashi T; Miyokawa N; Harabuchi Y; Ferrone S
    Clin Cancer Res; 2003 Sep; 9(11):4043-51. PubMed ID: 14519625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of cellular immunity lacks prognostic significance in vulvar squamous carcinoma.
    de Jong RA; Toppen NL; Ten Hoor KA; Boezen HM; Kema IP; Hollema H; Nijman HW
    Gynecol Oncol; 2012 Apr; 125(1):186-93. PubMed ID: 22155674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of CD45Ro
    Koike K; Nishiyama K; Dehari H; Ogi K; Sasaki T; Shimizu S; Sasaya T; Tsuchihashi K; Sonoda T; Hasegawa T; Hiratsuka H; Miyazaki A
    Anticancer Res; 2021 Sep; 41(9):4515-4522. PubMed ID: 34475077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival.
    Tsuchikawa T; Ikeda H; Cho Y; Miyamoto M; Shichinohe T; Hirano S; Kondo S
    Clin Exp Immunol; 2011 Apr; 164(1):50-6. PubMed ID: 21352198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
    Jordanova ES; Gorter A; Ayachi O; Prins F; Durrant LG; Kenter GG; van der Burg SH; Fleuren GJ
    Clin Cancer Res; 2008 Apr; 14(7):2028-35. PubMed ID: 18381941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
    Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
    Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma.
    Lo Muzio L; Leonardi R; Mariggiò MA; Mignogna MD; Rubini C; Vinella A; Pannone G; Giannetti L; Serpico R; Testa NF; De Rosa G; Staibano S
    Histol Histopathol; 2004 Jan; 19(1):119-28. PubMed ID: 14702179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.
    de Groot AF; Blok EJ; Charehbili A; Engels CC; Smit VTHBM; Dekker-Ensink NG; Putter H; Meershoek-Klein Kranenbarg E; van de Velde CJH; Liefers GJ; Nortier JWR; Kuppen PJK; van der Burg SH; Kroep JR
    Breast Cancer Res Treat; 2019 Jun; 175(3):605-615. PubMed ID: 30868392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
    Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.